A carregar...
Ridinilazole: a novel antimicrobial for Clostridium difficile infection
Clostridium difficile (C. difficile) infection remains a global healthcare threat worldwide and the limited options available for its treatment are of particular concern. Ridinilazole is one potential future agent, as it demonstrates rapid bactericidal activity against C. difficile. Current studies...
Na minha lista:
| Publicado no: | Ann Gastroenterol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hellenic Society of Gastroenterology
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6394264/ https://ncbi.nlm.nih.gov/pubmed/30837785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2018.0336 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|